By Michelle Marchante, Miami Herald (TNS) MIAMI — As her students finished their online exam, Arlet Lara got up to make a cafe con leche . Her 16-year-old son found her on the kitchen floor. First, he called Dad in a panic. Then 911. “I had a stroke and my life made a 180-degree turn,” Lara told the Miami Herald, recalling the medical scare she experienced in May 2020 in the early months of the COVID pandemic. “The stroke affected my left side of the body,” the North Miami woman and former high school math teacher said. Lara, an avid runner and gym goer, couldn’t even walk. “It was hard,” the 50-year-old mom said. After years of rehabilitation therapy and a foot surgery, Lara can walk again. But she still struggles with moving. This summer, she became the first patient in South Florida to get an implant of a new and only FDA-approved nerve stimulation device designed to help ischemic stroke survivors regain movement in their arms and hands. This first procedure was at Jackson Memorial Hospital in Miami. Lara’s rehab was at at the Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis, part of a partnership between Jackson Health System and UHealth. Every year, thousands in the United States have a stroke , with one occurring every 40 seconds, according to the U.S. Centers for Disease Control and Prevention. The majority of strokes are ischemic, often caused by blood clots that obstruct blood flow to the brain. For survivors, most of whom are left with some level of disability, the Vivistim Paired VNS System, the device implanted in Lara’s chest, could be a game changer in recovery, said Dr. Robert Starke, a UHealth neurosurgeon and interventional neuroradiologist. He also serves as co-director of endovascular neurosurgery at Jackson Memorial Hospital, part of Miami-Dade’s public hospital system. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant designed to help stroke survivors regain function in their arms, goes through exercises while her therapist activates the device during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA- approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) The Vivistim Paired VNS System is a small pacemaker-like device implanted in the upper chest and neck area. Patients can go home the same day. The U.S. Food and Drug Administration approved the stroke rehabilitation system in 2021 to be used alongside post-ischemic stroke rehabilitation therapy to treat moderate to severe mobility issues in hands and arms. Lara’s occupational therapist can activate the device during rehabilitation sessions to electrically stimulate the vagus nerve, which runs from the brain down to the abdomen and regulates various parts of the body’s nervous system. The electrical stimulation rewires the brain to improve a stroke survivor’s ability to move their arms and hands. Lara also has a magnet she can use to activate the device when she wants to practice at home. Her therapy consists of repetitive tasks, including coloring, pinching cubes and grabbing and releasing cylindrical shapes. After several weeks of rehabilitation therapy with the device, Lara has seen improvement. “Little by little, I’m noticing that my hand is getting stronger. I am already able to brush my teeth with the left hand,” she told the Miami Herald in September. Since then, Lara has finished the initial six-week Vivitism therapy program, and is continuing to use the device in her rehabilitation therapy. She continues to improve and can now eat better with her left hand and can brush her hair with less difficulty, according to her occupational therapist, Neil Batungbakal. Lara learned about the device through an online group for stroke survivors and contacted the company to inquire. She then connected them with her Jackson medical team. Now a year later, the device is available to Jackson patients. So far, four patients have received the implant at Jackson. Starke sees the device as an opportunity to help bring survivors one step closer to regaining full mobility. Strokes are a leading cause of disability worldwide. While most stroke survivors can usually recover some function through treatment and rehabilitation, they tend to hit a “major plateau” after the first six months of recovery, he said. Vivistim, when paired with rehabilitation therapy, could change that. Jackson Health said results of a clinical trial published in the peer-reviewed medical journal The Lancet in 2021 showed that the device, “when paired with high-repetition, task-specific occupational or physical therapy, helps generate two to three times more hand and arm function for stroke survivors than rehabilitation therapy alone.” The device has even shown to benefit patients 20 years from their original stroke, according to Starke. “So now a lot of these patients that had strokes 10-15 years ago that thought that they would never be able to use their arm in any sort of real functional way are now able to have a real meaningful function, which is pretty tremendous,” Starke said. Vivistim’s vagus-nerve stimulation technology was developed by researchers at the University of Texas at Dallas’ Texas Biomedical Device Center and is being sold commercially by Austin-based MicroTransponder, a company started by university graduates. Similar devices are used to treat epilepsy and depression . For Lara, the device is a new tool to help her recovery journey. “Everything becomes a challenge so we are working with small things every day because I want to get back as many functions as possible,” Lara said. Patients interested in Vivistim should speak with their doctor to check their eligibility. The FDA said patients should make sure to discuss any prior medical history, including concurrent forms of brain stimulation, current diathermy treatment, previous brain surgery, depression, respiratory diseases and disorders such as asthma, and cardiac abnormalities. “Adverse events included but were not limited to dysphonia (difficulty speaking), bruising, falling, general hoarseness, general pain, hoarseness after surgery, low mood, muscle pain, fracture, headache, rash, dizziness, throat irritation, urinary tract infection and fatigue,” the FDA said. MicroTransponder says the device is “covered by Medicare, Medicaid, and private insurance with prior authorization on a case-by-case basis.” To learn more about the device, visit vivistim.com. ©2024 Miami Herald. Visit at miamiherald.com. Distributed by Tribune Content Agency, LLC.The Bharatiya Janata Party’s resounding victory in the bypolls to nine assembly seats in Uttar Pradesh has re-established chief minister Yogi Adityanath’s charisma in state politics that took a hit after the ruling party suffered a setback in the 2024 Lok Sabha elections. Adityanath not only led the BJP campaign from front by holding multiple rallies for the bypolls across constituencies , but also set the tone with the slogan “batenge toh katenge, ek rahenge to nek rahenge” (will be slaughtered if divided, unity will make us worthy)”. The slogan could have backfired after the Opposition parties launched a scathing attack on Yogi, alleging that he was trying to create fear among a section of the people. Some senior BJP leaders distanced themselves from the controversial slogan, bringing the differences in the party into the open. Nevertheless, confident that the slogan will win seats for the party, Yogi continued his aggressive campaign, taking the slogan to all the nine Uttar Pradesh assembly seats as well as Maharashtra and Jharkhand where he sought votes for the BJP candidates. Ignoring the Opposition attack, Adityanath moved ahead with the slogan saying: “Batiye mat, jab bhi bate the toh kate the, ek hain toh nek hain (Do not get divided, when we are divided, we were slaughtered, unity will ensure safety and strength)” at public meetings. Lauding the BJP’s victory in the bypolls, Yogi, in a post on social media platform X on Saturday, reasserted confidence in his slogan “batenge toh katenge, ek rahenge to safe rahenge” (If we are divided we will be destroyed. If we stay united we will be safe). This indicated that his slogan effectively countered SP chief Akhilesh Yadav’s slogan “judenge toh jitenge”. In Uttar Pradesh, the BJP-led NDA not only retained five seats -- Ghaziabad, Khair, Phulpur, Manjhawa and Meerapur -- that it had won in the 2022 assembly election but succeeded in wresting two seats -- Kundarki and Katehari -- from the Samajwadi Party. Both the seats were considered SP strongholds. The BJP had won the Kundarki seat once in the 1993 assembly election and the Katehari seat in the 1991 assembly election. Riding on the PDA formula, the Samajwadi Party (SP) bagged 37 seats in the Lok Sabha election in UP in June while the BJP suffered a setback in its strong fort where its tally was reduced to 33 seats in 2024 from 62 in 2019. The debacle led to rumblings in the BJP as senior leaders not only alleged neglect of the organisation but also raised question over the capability of Yogi to win the election. Immediately after the Lok Sabha election, Adityanath swung into action when the Election Commission of India started preparations in July for the assembly bypolls, seeing an opportunity to restore the party’s prestige and to send a message to opponents that his charisma has not eroded. He was given a free hand by the BJP central leadership in drawing the strategy for the by-election and in the selection of candidates. He undertook whirlwind visits to all the constituencies, holding meetings with local party leaders and workers to draw the strategy for the campaign. He addressed a series of public meetings in all these constituencies. He also constituted groups of three ministers, allotting one constituency to each group and tasking them with completing the groundwork for the campaign. Adityanath chaired high-level meetings of the top state BJP leaders organised in the party office as well as at his official residence to give a momentum to the campaign. Sinking differences, the BJP presented a united front under the leadership of the chief minister with deputy chief ministers Keshav Prasad Maurya and Brajesh Pathak addressing public meetings in the OBC and upper caste-dominated areas. To woo the youths, the state government organised “rozgar melas” in nine assembly constituencies and announced the launch of various schemes for farmers and women. The victory of the BJP by comfortable margin in the seven seats indicates the support of the youth, women and farmers. A political observer AK Mishra said the BJP alliance’s victory in the Muslim dominated seats of Kundarki and Meerapur clearly indicates that Yogi Adityanath’s slogan “batenge toh katenge” hit the bullseye in the election in polarisaring the Hindu community -- upper castes, OBC and Dalits in support of the BJP and RLD candidates and breaking the PDA formula that have worked in favour of the SP in the Lok Sabha election.
Owaisi asks party workers not to lose heart with Maha poll results
Physics-Bending Platformer Bionic Bay Warps onto PS5 in March 2025
Households use Black Friday sales to update the wardrobe
Lawmakers call for progress on marijuana law before end of Biden administration
CHICAGO (AP) — Mark Scheifele snapped a third-period tie and Kyle Connor had two assists, helping the Winnipeg Jets beat Chicago 4-2 on Saturday in the first game for interim Blackhawks coach Anders Sorensen. Mason Appleton had a goal and an assist as the Jets picked up their second straight win after a four-game losing streak. Nino Niederreiter and Gabriel Vilardi also scored, and Connor Hellebuyck made 12 saves. Sorensen was promoted from the team's top minor league affiliate when Luke Richardson was fired on Thursday. Alex Vlasic scored for the second straight game for Chicago, which has dropped five in a row. Alec Martinez added his first goal of the season. The Blackhawks had a 2-1 lead before Niederreiter converted a backhander 13:10 into the second, beating Arvid Soderblom. It was Niederreiter's 10th of the season. Soderblom entered 11 minutes into the game when Petr Mrazek appeared to aggravate a right groin pull. Appleton had an empty-net goal with 1:41 to play. Jets: Winnipeg outplayed Chicago in the final 30 minutes, not only in shots but in puck possession. Blackhawks: Chicago played with more pace but it still struggled to get the puck to the net. They had only 14 shots on goal. Scheifele beat Jason Dickinson on the face-off that led to Winnipeg’s go-ahead goal. He slid the puck to Connor, then raced to the net for the rebound at 10:18. Blackhawks coaches, interim or full-time, are 6-7-1 in their first game behind the bench since the beginning of the 1995-96 season. Richardson lost his debut at the beginning of the 2022-23 season. The Jets begin a four-game homestand against Columbus on Sunday. The Blackhawks are in New York on Monday night to play the Rangers. AP NHL: https://apnews.com/hub/nhlSKorea arrests ex-defence minister over martial law
How to get started with Bluesky
NEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Winnebago Industries, Inc. (NYSE: WGO) resulting from allegations that Winnebago may have issued materially misleading business information to the investing public. If you invested in Winnebago securities, you are encouraged to obtain additional information by visiting https://rosenlegal.com/case/winnebago-industries-inc/ . Why Did Winnebago Industries’ Stock Drop? On September 23, 2024, during market hours, Hunterbrook Media published an article called “‘Grand Deception’- Winnebago Muzzles Outcry Over Major Problem That Owners Say Makes RVs Dangerous, Untowable, Worthless.” In this article, Hunterbrook said Winnebago’s “best-selling Grand Design RVs” appear to be “experiencing frame failure, potentially affecting thousands of units sold for more than a billion dollars. This defect has led to costly damage and potential safety hazards, and rendered some RVs unroadworthy.” Further, the article stated “Winnebago has used NDAs, buybacks, and online censorship to silence complaints about frame failure[.]” On this news, Winnebago’s stock fell $1.35 per share, or 2.28%, to close at $57.76 per share on September 23, 2024. Click here for more information: https://rosenlegal.com/case/winnebago-industries-inc/ . What Can You Do? If you invested in Winnebago Industries, you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: https://rosenlegal.com/submit-form/?case_id=29071 . Why Rosen Law Firm? We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. For more information about Rosen Law and its attorneys, please visit https://rosenlegal.com/ . Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ . Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com
Thousands demand lower rents at Barcelona demoW3SA: Redefining Surveys with Web3 Innovation and Community RewardsMyscha Theriault: Geocaching is the free vacation activity that’s hiding in plain sight
India News | BJP Dreaming to Win Polls with Money Power: Bengal Party MLA After Bypoll Loss
Providence, Oklahoma hope key players are back in Bahamas